P. Kent Hawryluk insider trades

Open-market stock purchases and sales by P. Kent Hawryluk, President & CEO at MBX Biosciences, Inc, from SEC Form 4 filings since Aug 4, 2016.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +104%.

Recent trades

DateStockTradeValue
May 6, 2026MBX MBX Biosciences, IncSold$17.9K
Mar 13, 2026MBX MBX Biosciences, IncBought$526K
Feb 26, 2026MBX MBX Biosciences, IncBought (not open market)—
Feb 2, 2026MBX MBX Biosciences, IncBought (not open market)—
Feb 2, 2026MBX MBX Biosciences, IncBought (not open market)—
Oct 24, 2025MBX MBX Biosciences, IncBought (not open market)—
Oct 20, 2025MBX MBX Biosciences, IncBought$273K

Companies traded

  • MBX MBX Biosciences, Inc: 3 buys, 1 sale, last May 6, 2026
  • GEMP Gemphire Therapeutics Inc: 3 buys, last Jan 29, 2018

Get free alerts when P. Kent Hawryluk files a new trade →